Abstracts
30 Lumateperone (ITI-007) for the Treatment of Schizophrenia: Overview of Placebo-Controlled Clinical Trials and an Open-label Safety Switching Study
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 190-191
-
- Article
-
- You have access
- Export citation
31 A Modified-Release Drug Delivery Technology Containing Amphetamine-Ion Exchange Complexes
-
- Published online by Cambridge University Press:
- 12 March 2019, p. 191
-
- Article
-
- You have access
- Export citation
32 Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 191-192
-
- Article
-
- You have access
- Export citation
33 An Intervention to Decrease Benzodiazepine Prescribing by Providers in an Urban Clinic
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 192-193
-
- Article
-
- You have access
- Export citation
34 Long-Term Deutetrabenazine Treatment Response in Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonists and Baseline Comorbidities
-
- Published online by Cambridge University Press:
- 12 March 2019, p. 193
-
- Article
-
- You have access
- Export citation
35 Long-term Improvements in Site-Rated Outcomes with Deutetrabenazine Treatment in Patients with Tardive Dyskinesia
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 193-194
-
- Article
-
- You have access
- Export citation
36 Too Scared to Blink: Pseudoparkinsonism due to Nyctophobia
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 194-195
-
- Article
-
- You have access
- Export citation
38 Global Improvement and Patient Satisfaction: Results from a Long-term, Open-label, Rollover Study of Valbenazine in Tardive Dyskinesia
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 195-196
-
- Article
-
- You have access
- Export citation
39 Long-term Safety and Tolerability of Once-Daily Valbenazine in Patients with Tardive Dyskinesia
-
- Published online by Cambridge University Press:
- 12 March 2019, p. 196
-
- Article
-
- You have access
- Export citation
40 Pseudo Cranial Nerve I Dysfunction: Subjective Hyposmia and Subjective Hypogeusia but Normosmia and Normogeusia - 3 cases
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 196-197
-
- Article
-
- You have access
- Export citation
41 A Modified Delphi Consensus Approach to Clinical Guidelines for Tardive Dyskinesia
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 197-198
-
- Article
-
- You have access
- Export citation
42 Training Forgiveness – A Novel Approach to Reducing Physician Burnout
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 198-199
-
- Article
-
- You have access
- Export citation
43 Tinnitus as an Aura for Sleep Paralysis
-
- Published online by Cambridge University Press:
- 12 March 2019, p. 199
-
- Article
-
- You have access
- Export citation
44 Real World Effectiveness: A 6-month Naturalistic Follow-up Study of Schizophrenia Patients After Switching to Aripiprazole Monohydrate (AOM) Treatment
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 199-200
-
- Article
-
- You have access
- Export citation
45 Long-term Treatment with Deutetrabenazine Is Associated with Continued Improvement in Tardive Dyskinesia: Results from an Open-label Extension Study
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 200-201
-
- Article
-
- You have access
- Export citation
46 Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-label Extension Study
-
- Published online by Cambridge University Press:
- 12 March 2019, p. 201
-
- Article
-
- You have access
- Export citation
47 Sustained Functional Recovery and Symptom Remission After Maintenance Treatment with Aripiprazole Once-Monthly for Patients with Bipolar I Disorder
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 201-202
-
- Article
-
- You have access
- Export citation
49 Combinatorial Pharmacogenomics to Guide Treatment Selection for Major Depressive Disorder: A Large, Blinded, Randomized Controlled Trial
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 202-203
-
- Article
-
- You have access
- Export citation
50 Adjunctive Buprenorphine/Samidorphan Combination in Patients with Major Depressive Disorder: Phase 3 Long-term Extension Study Results
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 203-204
-
- Article
-
- You have access
- Export citation
53 Computer Vision, Facial Expressivity and Schizophrenia: A Review
-
- Published online by Cambridge University Press:
- 12 March 2019, pp. 204-205
-
- Article
-
- You have access
- Export citation